Home
  • Home
  • Resources
  • Diseases
  • Training
  • SYSVAC
    • About
    • Registry
    • E-learning course
  • News
  • Events
  • Network
    • Vision and Mission
    • Steering Committee
    • Map
    • Meetings
    • Join us
  • Home
  • Diseases
  • Malaria
Diseases

Malaria

malaria virus
SAGE recommendations and background documents
Find out more
2022 ∙ SAGE
Malaria vaccine: WHO position paper
Download:
  • EN
  • FR
  • Position paper
  • Malaria
2022
Health Utilisation Study (HUS) Round 2 - cross-country report on findings from the Primary Child Caregiver cohort sample
Download:
  • EN
  • SAGE background document
  • Malaria
2022 ∙ SAGE
Modelled public health impact and cost effectiveness estimates of RTS,S/AS01 malaria vaccine in perennial and seasonal settings (August 2021)
Download:
  • EN
  • SAGE background document
  • Malaria
2022 ∙ SAGE
Statistical report on the results of the RTS,S/AS01 Malaria Vaccine Pilot Evaluation 24 months after the vaccine was introduced (September 2021, v1.2)
Download:
  • EN
  • SAGE background document
  • Malaria
2022 ∙ SAGE
Full Evidence Report on the RTS,S/AS01 Malaria Vaccine
Download:
  • EN
  • SAGE background document
  • Malaria
2022 ∙ SAGE
GRADE and Evidence to Recommendation tables on RTS,S/AS01 malaria vaccine
Download:
  • EN
  • Evidence to recommendation table
  • Malaria
2015
Mosquirix: Opinion on medicine for use outside EU
Download:
  • EN
  • SAGE background document
  • Malaria
Other critical evidence
2021 ∙ Daniel Chandramohan, Brian Greenwood
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention
Download:
  • EN
  • Malaria
2019 ∙ Halidou Tinto, Walter Otieno, Samwel Gesase, Hermann Sorgho, Lucas Otieno
Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial
Download:
  • EN
  • Malaria
2015 ∙ RTS,S Clinical Trials Partnership
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
Download:
  • EN
  • Malaria
External links
Full Evidence Report on the RTS,S/AS01 Malaria Vaccine
Link:
  • EN
Q&A on RTS,S malaria vaccine
Link:
  • EN
  • FR
  • ES
Malaria vaccine implementation programme
Link:
  • EN
  • Home
  • Resources
  • Diseases
  • Training
  • SYSVAC
  • News
  • Events
  • Network
  • Sign in / Register
National Immunization Technical Advisory Groups
  • Home
  • Resources
  • Diseases
  • Training
  • SYSVAC
  • News
  • Events
  • Network
© 2022

Footer legal info

  • Legal Notice
Subscription to the monthly updates

On the last Wednesday of every month, we send updates about the latest NITAG recommendations in each region, relevant articles related to NITAG work, and other big announcements. Don’t miss them out!

Loading...